ARROWHEAD PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Arrowhead Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 1, 2024 was 124M shares, a 16% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 124M +17.1M +16% Aug 1, 2024 10-Q 2024-08-08
Q1 2024 124M +17.3M +16.2% May 1, 2024 10-Q 2024-05-09
Q4 2023 124M +15.6M +14.4% Jan 31, 2024 10-Q 2024-02-06
Q2 2023 107M +1.34M +1.27% Jul 31, 2023 10-Q 2023-08-07
Q1 2023 107M +1.16M +1.1% Apr 24, 2023 10-Q 2023-05-02
Q4 2022 108M +2.85M +2.7% Feb 1, 2023 10-Q 2023-02-06
Q2 2022 106M +1.59M +1.53% Jul 28, 2022 10-Q 2022-08-04
Q1 2022 106M +1.65M +1.59% May 5, 2022 10-Q 2022-05-10
Q4 2021 105M +1.67M +1.61% Jan 31, 2022 10-Q 2022-02-02
Q2 2021 104M +1.97M +1.92% Aug 2, 2021 10-Q 2021-08-05
Q1 2021 104M +2.31M +2.27% Apr 30, 2021 10-Q 2021-05-04
Q4 2020 104M +2.14M +2.1% Feb 1, 2021 10-Q 2021-02-04
Q2 2020 102M +6.99M +7.34% Jul 27, 2020 10-Q 2020-08-05
Q1 2020 102M +6.96M +7.34% May 5, 2020 10-Q 2020-05-07
Q4 2019 102M +9.43M +10.2% Feb 3, 2020 10-Q 2020-02-05
Q2 2019 95.3M +7.28M +8.27% Aug 2, 2019 10-Q 2019-08-05
Q1 2019 94.8M +7.24M +8.26% May 6, 2019 10-Q 2019-05-08
Q4 2018 92.2M +17.4M +23.2% Dec 7, 2018 10-K 2018-12-11
Q2 2018 88M +13.3M +17.7% Aug 6, 2018 10-Q 2018-08-07
Q1 2018 87.6M +12.8M +17.1% May 7, 2018 10-Q 2018-05-08
Q4 2017 74.8M +655K +0.88% Dec 6, 2017 10-K 2017-12-12
Q2 2017 74.8M +14M +23.1% Aug 1, 2017 10-Q 2017-08-03
Q1 2017 74.8M +14.8M +24.7% May 2, 2017 10-Q 2017-05-03
Q4 2016 74.2M +14.6M +24.5% Dec 12, 2016 10-K 2016-12-14
Q2 2016 60.8M +1.25M +2.1% Aug 8, 2016 10-Q 2016-08-09
Q1 2016 60M +462K +0.78% May 9, 2016 10-Q 2016-05-10
Q4 2015 59.6M +4.76M +8.69% Dec 11, 2015 10-K 2015-12-14
Q2 2015 59.5M +6.59M +12.5% Jul 31, 2015 10-Q 2015-08-04
Q1 2015 59.5M +7.63M +14.7% May 8, 2015 10-Q 2015-05-11
Q4 2014 54.8M +16.1M +41.6% Feb 5, 2015 10-Q 2015-02-09
Q2 2014 52.9M +21.4M +67.8% Aug 11, 2014 10-Q 2014-08-12
Q1 2014 51.9M +20.6M +65.7% May 1, 2014 10-Q 2014-05-06
Q4 2013 38.7M +23.1M +147% Dec 16, 2013 10-K 2013-12-18
Q2 2013 31.5M +20.2M +179% Aug 5, 2013 10-Q 2013-08-07
Q1 2013 31.3M +20.1M +179% May 7, 2013 10-Q 2013-05-09
Q4 2012 15.6M +5.12M +48.6% Dec 21, 2012 10-K 2012-12-28
Q2 2012 11.3M -60.5M -84.3% Aug 3, 2012 10-Q 2012-08-13
Q1 2012 11.2M May 1, 2012 10-Q 2012-05-08
Q4 2011 10.5M Dec 15, 2011 10-K 2011-12-20
Q2 2011 71.8M Aug 1, 2011 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.